Servier, Singapore's A*STAR Ink Pack For Cancer, Immune Drugs
This article was originally published in PharmAsia News
Executive Summary
France-based drug maker Servier and A*STAR Singapore Immunology Network have signed an agreement to collaborate on three projects centered around using a person's immune system to target cancer and other drug treatments.